Determinants of Value in Coronary Artery Bypass Grafting

被引:7
作者
Brescia, Alexander A. [2 ,3 ]
Vu, Joceline V. [4 ]
He, Chang [8 ]
Li, Jun [1 ,6 ]
Harrington, Steven D. [9 ]
Thompson, Michael P. [2 ,3 ,8 ,10 ]
Norton, Edward C. [3 ,5 ,7 ,10 ]
Regenbogen, Scott E. [3 ,4 ,10 ]
Syrjamaki, John D. [4 ,10 ]
Prager, Richard L. [2 ,8 ]
Likosky, Donald S. [2 ,3 ,8 ]
机构
[1] Syracuse Univ, Maxwell Sch Citizenship & Publ Affairs, Dept Publ Adm & Internatl Affairs, Syracuse, NY USA
[2] Univ Michigan, Sch Publ Hlth, Michigan Med, Dept Cardiac Surg, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Sch Publ Hlth, Ctr Healthcare Outcomes & Policy, Ann Arbor, MI 48109 USA
[4] Univ Michigan, Sch Publ Hlth, Dept Surg, Ann Arbor, MI 48109 USA
[5] Univ Michigan, Sch Publ Hlth, Dept Econ, Ann Arbor, MI 48109 USA
[6] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA
[7] Univ Michigan, Sch Publ Hlth, Dept Hlth Management & Policy, Ann Arbor, MI 48109 USA
[8] Michigan Soc Thorac & Cardiovasc Surg Qual Collab, Ann Arbor, MI USA
[9] Henry Ford Macomb Hosp, Clinton Township, MI USA
[10] Michigan Value Collaborat, Ann Arbor, MI USA
来源
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES | 2020年 / 13卷 / 11期
基金
美国医疗保健研究与质量局;
关键词
coronary artery bypass; hospitalization; inpatient; length of stay; pneumonia; INFECTION-RATES; CARDIAC-SURGERY; CARE; PAYMENTS; QUALITY; FAILURE; SOCIETY;
D O I
10.1161/CIRCOUTCOMES.119.006374
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Over 180 000 coronary artery bypass grafting (CABG) procedures are performed annually, accounting for $7 to $10 billion in episode expenditures. Assessing tradeoffs between spending and quality contributing to value during 90-day episodes has not been conducted but is essential for success in bundled reimbursement models. We, therefore, identified determinants of variability in hospital 90-day episode value for CABG. Methods Medicare and private payor admissions for isolated CABG from 2014 to 2016 were retrospectively linked to clinical registry data for 33 nonfederal hospitals in Michigan. Hospital composite risk-adjusted complication rates (>= 1 National Quality Forum-endorsed, Society of Thoracic Surgeons measure: deep sternal wound infection, renal failure, prolonged ventilation >24 hours, stroke, re-exploration, and operative mortality) and 90-day risk-adjusted, price-standardized episode payments were used to categorize hospitals by value by defining the intersection between complications and spending. Results Among 2573 total patients, those at low- versus high-value hospitals had a higher percentage of prolonged length of stay >14 days (9.3% versus 2.4%, P=0.006), prolonged ventilation (17.6% versus 4.8%, P<0.001), and operative mortality (4.8% versus 0.6%, P=0.001). Mean total episode payments were $51 509 at low-compared with $45 526 at high-value hospitals (P<0.001), driven by higher readmission ($3675 versus $2177, P=0.005), professional ($7462 versus $6090, P<0.001), postacute care ($7315 versus $5947, P=0.031), and index hospitalization payments ($33 474 versus $30 800, P<0.001). Among patients not experiencing a complication or 30-day readmission (1923/2573, 74.7%), low-value hospitals had higher inpatient evaluation and management payments ($1405 versus $752, P<0.001) and higher utilization of inpatient rehabilitation (7% versus 2%, P<0.001), but lower utilization of home health (66% versus 73%, P=0.016) and emergency department services (13% versus 17%, P=0.034). Conclusions To succeed in emerging bundled reimbursement programs for CABG, hospitals and physicians should identify strategies to minimize complications while optimizing inpatient evaluation and management spending and use of inpatient rehabilitation, home health, and emergency department services.
引用
收藏
页数:10
相关论文
共 50 条
[31]   Prediction of Costs and Length of Stay in Coronary Artery Bypass Grafting [J].
Osnabrugge, Ruben L. ;
Speir, Alan M. ;
Head, Stuart J. ;
Jones, Philip G. ;
Ailawadi, Gorav ;
Fonner, Clifford E. ;
Fonner, Edwin, Jr. ;
Kappetein, A. Pieter ;
Rich, Jeffrey B. .
ANNALS OF THORACIC SURGERY, 2014, 98 (04) :1286-1293
[32]   Chylothorax After Coronary Artery Bypass Grafting [J].
Halldorsson, Ari .
INTERNATIONAL SURGERY, 2009, 94 (02) :119-129
[33]   Coronary artery bypass grafting and paraparesis; is there a correlation? [J].
Samiotis, Ilias ;
Baikoussis, Nikolaos G. ;
Patris, Vasileios ;
Argiriou, Michalis ;
Dedeilias, Panagiotis ;
Charitos, Christos .
CARDIOVASCULAR JOURNAL OF AFRICA, 2018, 29 (01) :E6-E8
[34]   Postoperative Management of Coronary Artery Bypass Grafting [J].
Raja, Shahzad Gull .
HEART SURGERY FORUM, 2025, 28 (06) :E462-E475
[35]   Barriers to Multiarterial Coronary Artery Bypass Grafting [J].
Waterford, Stephen D. .
INNOVATIONS-TECHNOLOGY AND TECHNIQUES IN CARDIOTHORACIC AND VASCULAR SURGERY, 2024, 19 (04) :345-350
[36]   Neurological complications of coronary artery bypass grafting [J].
Shrader, N. I. ;
Shaibakova, V. L. ;
Likhvantsev, V. V. ;
Levikov, D. I. ;
Levin, O. S. .
ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2012, 112 (03) :76-81
[37]   Coronary artery bypass grafting in conscious patients [J].
Byhahn, C. ;
Meininger, D. ;
Kessler, P. .
ANAESTHESIST, 2008, 57 (12) :1144-+
[38]   Quality metrics in coronary artery bypass grafting [J].
Khan, Faiza M. ;
Hameed, Irbaz ;
Milojevic, Milan ;
Wingo, Matthew ;
Krieger, Katherine ;
Girardi, Leonard N. ;
Prager, Richard L. ;
Gaudino, Mario .
INTERNATIONAL JOURNAL OF SURGERY, 2019, 65 :7-12
[39]   Current status of coronary artery bypass grafting [J].
Kobayashi J. .
General Thoracic and Cardiovascular Surgery, 2008, 56 (6) :260-267
[40]   Effect of aspirin in coronary artery bypass grafting [J].
Vuylsteke, A ;
Oduro, A ;
Cardan, E ;
Latimer, RD .
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 1997, 11 (07) :831-834